FindTrial
Sign In

A study of 254nm UVC ray therapy in pharynx for asymptomatic to mild cases of Corona Virus Disease

Oronasopharyngeal 254 nm ultraviolet C therapy for asymptomatic to mild cases of Corona Virus Disease-2019: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025766
Enrollment
300
Registered
2020-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: 254 nm ultraviolet C rays : 254 nm ultraviolet C oronasopharyngeal exposure in dose of 2 mJ/cm2 once (repeat a dose if needed
maximum 2 doses) using a UV torch for 3 min add-on to the standard care Control Intervention1: Standard care: Standard care for COVID 19 given to patients as per applicable guideline

Sponsors

Dr Jagdeep Kakadia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 RT PCR confirmed asymptomatic or mild COVID-19 patients 2 The voluntary willingness of the patient to give written informed consent prior to participation in the trial

Exclusion criteria

Exclusion criteria: 1 History of known hypersensitivity to UV rays 2 Patients with active oral ulcers 3 Participating in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Proportion of patients virologicaly cured on (asymptomatic and mild cases) Proportion of patients clinically cured (mild cases)Timepoint: Day 1, 3, and 5—

Secondary

MeasureTime frame
1 To compare hospital stay duration 2 To assess adverse effects Timepoint: any time—

Countries

India

Contacts

Public ContactDr Jagdeep Kakadia

Akshardeep Eye Hospital

dr_jmkakadia@yahoo.com9825206858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026